[Prostaglandin E1 in newborn infants with ductus-dependent heart diseases. Review of 40 cases].
作者信息
Simões L C, Sarachaga I H, Quero M, Casanova M, Cazzaniga M, Villibre D
出版信息
Arq Bras Cardiol. 1985 Jul;45(1):31-6.
PMID:3938651
Abstract
摘要
相似文献
1
[Prostaglandin E1 in newborn infants with ductus-dependent heart diseases. Review of 40 cases].[前列腺素E1用于患有依赖动脉导管的心脏病的新生儿。40例病例回顾]
Arq Bras Cardiol. 1985 Jul;45(1):31-6.
2
Prostaglandin E1 treatment in patent ductus arteriosus dependent congenital heart defects.前列腺素E1治疗动脉导管未闭相关先天性心脏病。
J Perinat Med. 2004;32(4):368-74. doi: 10.1515/JPM.2004.069.
3
[Prostaglandin treatment of ductus-dependent congenital heart defects].[前列腺素治疗依赖动脉导管的先天性心脏缺陷]
Lakartidningen. 1984 Oct 3;81(40):3619-22.
4
5
Prostaglandins and the management of congenital heart disease.前列腺素与先天性心脏病的治疗
Am Fam Physician. 1982 Dec;26(6):127-32.
6
[Treatment of ductus-dependent congenital heart diseases with prostaglandin E1].
Ugeskr Laeger. 1979 Jul 9;141(28):1915-6.
7
8
Morphologic features of the ductus arteriosus after prostaglandin E1 administration for ductus-dependent congenital heart defects.给予前列腺素E1治疗动脉导管依赖性先天性心脏病后动脉导管的形态学特征。
J Am Coll Cardiol. 1983 Feb;1(2 Pt 1):471-5. doi: 10.1016/s0735-1097(83)80075-8.
9
Nursing care of the neonate receiving prostaglandin E1 therapy.接受前列腺素E1治疗的新生儿的护理
Neonatal Netw. 1993 Jun;12(4):17-22.
10
[Skeletal side effects of treatment with prostaglandin E1].[前列腺素E1治疗的骨骼副作用]
Rofo. 1984 Oct;141(4):427-30. doi: 10.1055/s-2008-1053163.
Zotero 插件